Literature DB >> 18073396

Diagnosis of pathogens in exacerbations of chronic obstructive pulmonary disease.

Annemarie Sykes1, Patrick Mallia, Sebastian L Johnston.   

Abstract

Chronic obstructive pulmonary disease (COPD) is increasing in prevalence. Acute exacerbations of COPD are the major cause worldwide of morbidity, mortality, and health care costs as well as decreased quality of life for the individual. The majority of exacerbations are infectious in etiology. Bacteria are detected in 50% of exacerbations and polymerase chain reaction techniques have established that, in half to two-thirds of exacerbations, viruses are causative pathogens. Combined bacterial and viral infection can be identified in 25% of exacerbations and these dual infections are often more severe. Despite occurring frequently, the mechanisms by which infection with these pathogens causes exacerbations are incompletely understood. This highlights the need for continued research, because a greater understanding of the mechanism of COPD exacerbations may lead to identification of potential targets for the development of therapeutic options for this increasingly common condition.

Entities:  

Mesh:

Year:  2007        PMID: 18073396     DOI: 10.1513/pats.200707-101TH

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  15 in total

1.  Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease.

Authors:  Vasiliy V Polosukhin; Justin M Cates; William E Lawson; Rinat Zaynagetdinov; Aaron P Milstone; Pierre P Massion; Sebahat Ocak; Lorraine B Ware; Jae Woo Lee; Russell P Bowler; Alexey V Kononov; Scott H Randell; Timothy S Blackwell
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

Review 2.  The influence of virus infections on the course of COPD.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

3.  Pharmacological Management and Prevention Of Exacerbations of Chronic Obstructive Pulmonary Disease in Hospitalized Patients.

Authors:  Deepali Dixit; Mary Barna Bridgeman; Rani Patel Madduri; Samir T Kumar; Michael J Cawley
Journal:  P T       Date:  2016-11

Review 4.  Influencing the decline of lung function in COPD: use of pharmacotherapy.

Authors:  Ekaterina S Gladysheva; Atul Malhotra; Robert L Owens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

5.  Antibiotic Resistant and Virulence Determinants of Staphylococcus haemolyticus C10A as Revealed by Whole Genome Sequencing.

Authors:  Kok-Gan Chan; Kim Tien Ng; Teik Min Chong; Yong Kek Pang; Adeeba Kamarulzaman; Wai-Fong Yin; Kok Keng Tee
Journal:  J Genomics       Date:  2015-06-03

6.  Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease.

Authors:  Kristina Andelid; Anders Andersson; Shigemi Yoshihara; Christina Åhrén; Pernilla Jirholt; Ann Ekberg-Jansson; Anders Lindén
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-30

7.  Viral Profile of COPD Exacerbations According to Patients.

Authors:  Dimopoulos G; Tsiodras S; Lerikou M; Aik Chranioti; Perros E; Anagnostopoulou U; Karakitsos P; Armaganidis A
Journal:  Open Respir Med J       Date:  2015-02-23

8.  The main rhinovirus respiratory tract adhesion site (ICAM-1) is upregulated in smokers and patients with chronic airflow limitation (CAL).

Authors:  Shakti Dhar Shukla; Malik Quasir Mahmood; Steven Weston; Roger Latham; Hans Konrad Muller; Sukhwinder Singh Sohal; Eugene Haydn Walters
Journal:  Respir Res       Date:  2017-01-05

9.  Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.

Authors:  David L MacLeod; Lynn M Barker; Jennifer L Sutherland; Suzanne C Moss; Jesse L Gurgel; Thomas F Kenney; Jane L Burns; William R Baker
Journal:  J Antimicrob Chemother       Date:  2009-08-13       Impact factor: 5.790

10.  Utility of NT-proBNP for identifying LV failure in patients with acute exacerbation of chronic bronchitis.

Authors:  Qing-ping Wang; Xiao-zhi Cao; Xue-dong Wang; Juan Gu; Li-min Wen; Li-ming Mao; Ping-nan Shan; Ai-guo Tang
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.